Seattle Children’s opens CD22 CAR T-cell immunotherapy trial for … – Medical Xpress
|
Seattle Children’s opens CD22 CAR T-cell immunotherapy trial for …
Medical Xpress After seeing promising results in phase 1 of the Pediatric Leukemia Adoptive Therapy (PLAT-02) trial with 93 percent of patients with relapsed or refractory acute … |
|
Seattle Children’s Opens CD22 CAR T-Cell Immunotherapy Trial for Children and Young Adults Whose Leukemia …
PR Newswire (press release) SEATTLE, July 27, 2017 /PRNewswire-USNewswire/ — After seeing promising results in phase 1 of the Pediatric Leukemia Adoptive Therapy (PLAT-02) trial with 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving … |
The Scientist |
Stem Cells in the Hypothalamus Slow Aging in Mice
The Scientist Cai and his team found that killing hypothalamic neural stem cells accelerates aging, and transplantation additional neural stem cells into the brain region slows it down. Further, the stem cells‘ anti-aging effects could be reproduced simply by … 5 Ways To Reverse Aging: Science As The Fountain Of YouthInternational Business Times |
Labiotech.eu (blog) |
Swiss Researchers Unveil Cancer Immunotherapy Resistance …
Labiotech.eu (blog) Scientists from the University of Zurich have identified an epigenetic switch responsible for turning melanoma unresponsive to immune checkpoint inhibitors. Shedding Light on Cause of Resistance to Tumor ImmunotherapyDrug Discovery & Development |